Document is current
Any future updates will be listed below
-
Authors
,
Wadén, Jenny M.
Dahlström, Emma H.
Elonen, Nina
Thorn, Lena M.
Wadén, Johan
Sandholm, Niina
Forsblom, Carol
Groop, Per-Henrik
-
Funding
Funding for this research was provided by:
Novo Nordisk Foundation
Wilhelm and Else Stockmann Foundation
Maud Kuistila Foundation
Waldemar von Frenckell Foundation
Liv och Hälsa Foundation
Emil Aaltosen Säätiö
Academy of Finland
Folkhälsan Research Foundation
- License Information
-
More Information
Article History
Received: 28 September 2018
Accepted: 26 March 2019
First Online: 24 May 2019
Duality of interest
: The authors declare that there are no conflicts of interest associated with this manuscript. P-HG has received lecture honoraria from Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Genzyme, MSD, Novartis, Novo Nordisk and Sanofi. P-HG is an advisor for AbbVie, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, MSD, Novartis, Novo Nordisk and Sanofi. P-HG has received investigator-initiated grants from Eli Lilly and Roche.
